Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LHCGR | P22888 | 9/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 0.68 |
| ▸ | FSHR | P23945 | 2/20 | 0.52 |
| ▸ | BRAF | P15056 | 2/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | CRHBP | P24387 | 1/20 | 0.40 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.40 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.40 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.40 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4321104 | 0.90 | LHCGR (1.00) | LHCGRTSHRFSHRBRAFCHRM4 | |
| SCHEMBL4326072 | 0.81 | LHCGR (1.00) | LHCGRTSHRFSHRBRAFCHRM4 | |
| SCHEMBL32156160 | 0.81 | LHCGR (1.00) | LHCGRTSHRFSHRBRAFCHRM4 | |
| SCHEMBL4313210 | 0.80 | LHCGR (1.00) | LHCGRTSHRFSHRBRAFCHRM4 | |
| SCHEMBL4421168 | 0.78 | LHCGR (0.84) | LHCGRTSHRFSHRBRAFCHRM4 | |
| SCHEMBL5037288 | 0.78 | LHCGR (0.70) | LHCGRTSHRFSHRBRAFMEN1 | |
| SCHEMBL4315364 | 0.77 | LHCGR (1.00) | LHCGRTSHRFSHRBRAFCHRM4 | |
| SCHEMBL5037092 | 0.77 | LHCGR (0.87) | LHCGRTSHRFSHRBRAFCHRM4 | |
| SCHEMBL4425902 | 0.77 | LHCGR (0.78) | LHCGRTSHRFSHRBRAF | |
| SCHEMBL4325936 | 0.76 | LHCGR (0.71) | LHCGRTSHRFSHRBRAFCHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090203716-A1 | Pyrimidine low molecular weight ligands for modulating hormone receptors | The Government of the United States of America as represented by the Secretary of the | 2009-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203716-A1 | Pyrimidine low molecular weight ligands for modulating hormone receptors | FSHR, TSHR, TRHR | LHCGR 5/4885TSHR 2/4885FSHR 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.